Welcome to the Cardiogenics Holdings Discussion Forum

Paramagnetic Beads and QL Analyser are Proprietary Products

Free
Message: Twelve Weeks of Enrollment Have Passed

The twelve week enrollment period for the Beta Site study has passed; if the study is not fully enrolled, IMO, Cardiogenics should announce such.

If the study is fully enrolled, Cardiogenics should know the results soon and, thus, initiate the FDA 200 patient study within the next few weeks. A couple of informative Press Releases IMO will be coming our way if this scenario unfolds.

Ante

Share
New Message
Please login to post a reply